Search clinical trials for: K-877-ER (Dose B)

Total 437 results

Jiangsu Province Centers for Disease Control and...
Beijing Tiantan Biological Products Co., Ltd.

Completed

Study of Evaluating Safety and Immunogenicity of 10µg/0.5ml Hepatitis B Vaccine

Hepatitis B

China
Takeda
Intra-Cellular Therapies, Inc.

Terminated

Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia

Schizophrenia

United States
Société des Produits Nestlé (SPN)

Completed

Oral CDX-7108 in Healthy Adults and EPI Subjects

Exocrine Pancreatic Insufficiency

Australia, New Zealand
Institut Pasteur
Institut National de la Santé Et de la Recherche Médicale, France; Gilead Sciences and other collaborators

Completed

Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunization Schedule (NEOVAC2BK)

Hepatitis B

Burkina Faso
AC Immune SA
Worldwide Clinical Trials

Recruiting

A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

Alzheimer's Disease | Prodromal Alzheimer's Disease | Amyloid Plaque | Beta-Amyloid | Alzheimer's Disease in Down Syndrome

United States, Spain, United Kingdom
Federal University of Health Science of Porto Alegre

Not yet recruiting

Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS (L-AmB_phase3)

Fungal Infection | Immunosuppression | AIDS and Infections | Disseminated Histoplasma Capsulatum Infection

Brazil
Tianjin Chasesun Pharmaceutical Co., LTD
Southwest Hospital, China

Completed

Study of Multiple-dose Kukoamine B Mesilate in Healthy Volunteers

Healthy

China
AC Immune SA
ICON Clinical Research

Recruiting

A Study to Evaluate the Effects of ACI-7104.056 Vaccination in Patients With Early Stages of Parkinson's Disease (VacSYn)

Parkinson Disease | Parkinson Disease 6, Early-Onset

United Kingdom, Spain, Germany
Novartis Vaccines
GlaxoSmithKline

Completed

Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Women

Group B Streptococcus

Belgium
Lesaffre International
Biofortis Mérieux Nutriscience

Completed

Effect of Oral Probiotic Yeast on the Composition of the Vaginal Microbiota in Healthy Women

Vaginal Health

France
AbbVie

Completed

Study to Evaluate the Relative Bioavailability of Two Risankizumab Drug Product Presentations in Healthy Volunteers.

Healthy Volunteers

United States
Gilead Sciences

Not yet recruiting

A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments

HIV-1-infection
Dr. Reddy's Laboratories Limited

Completed

An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation

Pediculosis

United States
Augusta University
Yale University; University of Alabama at Birmingham; Tufts University

Unknown

Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K 'n' Kids Study)

Obesity | Diabetes | Insulin Resistance | Dyslipidemia | Insulin Sensitivity | Prediabetes

United States
National Cancer Institute (NCI)

Completed

E7389 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Recruiting

Safety, Tolerability, and Immunogenicity of Recombinant Meningococcal Group B Vaccine (E.Coli)

Healthy Volunteers

China
GlaxoSmithKline

Terminated

A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS)

Multiple Sclerosis, Relapsing-Remitting

United Kingdom
Glenn Bauman
London Health Sciences Foundation

Active, not recruiting

Radioligand fOr locAl raDiorecurrent proStaTe cancER (ROADSTER)

Prostate Cancer

Canada
GlaxoSmithKline

Completed

Fosamprenavir in Pts With Hepatic Impairment

Infection, Human Immunodeficiency Virus
Shionogi

Completed

Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy

Type 2 Diabetes Mellitus

United States
Merck Sharp & Dohme LLC

Completed

Relative Bioavailability Study of Subcutaneous Injection Versus Intravenous Infusion of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-555/KEYNOTE-555)

Melanoma

Australia, South Africa, Spain, Sweden
BLIS Technologies Limited

Not yet recruiting

Colonisation of Scalp by Topical Probiotic Micrococcus Luteus Q24

Microbial Colonization

New Zealand
Gilead Sciences

Recruiting

Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children With Human Immunodeficiency Virus-1

HIV-1 Infection

United States, Thailand, Uganda, South Africa
Novartis Vaccines

Completed

Persistence of Antibody Levels and Response to Fifth or Third Meningococcal B Recombinant Vaccine in 4-year Old Healthy Children Who Previously Participated in Study V72P12E1

Meningococcal Disease | Meningococcal Meningitis

Spain, Italy, United Kingdom, Czech Republic
BLIS Technologies Limited

Active, not recruiting

Colonization of Skin by M. Luteus Q24 Probiotic

Microbial Colonization

New Zealand
Institut Pasteur

Completed

Study to Evaluate the Dosage and Safety of Two Intramuscular Injections of an Investigational Clade B HIV Vaccine

HIV

Belgium
Shanxi Medical University
Centers for Disease Control and Prevention, China

Completed

Immunogenicity of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients

Hepatitis B Vaccine
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

Major Depressive Disorder

Japan
Novartis Pharmaceuticals

Completed

Assess Bronchodilator Effect QVM149 Dosed Either in the Morning or Evening Compared to Placebo in Patients With Asthma (QVM149)

Asthma

Germany, Netherlands, United Kingdom
ONL Therapeutics

Active, not recruiting

A Phase 1b Study of ONL1204 Ophthalmic Solution in Patients With Progressing Open Angle Glaucoma

Open Angle Glaucoma

Australia, New Zealand
Pfizer

Completed

A Study to Investigate the Effect of Tablet Formulation and Food on PF-07104091 in Healthy Participants

Healthy

United States
Stragen France

Completed

First-In-Human PainCart Study for STR-324

Pain

Netherlands
Augusta University
Yale University; University of Alabama at Birmingham; Tufts University

Unknown

Vitamin K and Glucose Metabolism in Adults at Risk for Diabetes (Vita-K 'n' Adults Study)

Obesity | Insulin Resistance | Insulin Sensitivity | Prediabetes | Beta-Cell Dysfunction

United States
ViSci Ltd.

Completed

A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open Angle Glaucoma

United States
National Cancer Institute (NCI)

Completed

Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma

Recurrent Osteosarcoma

United States, Canada
University of Texas Southwestern Medical Center

Recruiting

Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones

Calcium Phosphate Kidney Stones

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites (0524A-079)(COMPLETED)

Type 2 Diabetes Mellitus
Amway (China) R&D Center

Recruiting

The Efficacy of Amway Uric Acid Lowering Product on Hyperuricemia

Hyperuricemia

China
Organon and Co

Completed

To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)

Hypercholesterolemia
Peking University
National Natural Science Foundation of China; Institute of reproductive and...

Completed

Effects of Low-dose Complex B-vitamins on Homocysteine and Framingham Risk Score Among Chinese Elderly

Hyperhomocysteinemia

China
Bristol-Myers Squibb

Completed

Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA)

Active Psoriatic Arthritis

Spain, United States, Hungary, Germany, Poland, United Kingdom, Russian Federation, Italy, Czechia
Sanofi Pasteur, a Sanofi Company

Recruiting

Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate

Healthy Volunteers | Respiratory Syncytial Virus Infection | Human Metapneumovirus

United States, Puerto Rico
American Heart Association

Completed

Improving Outcomes In Diabetic Patients During CABG Surgery By Optimizing Glycemic Control

Glycemic Control

United States
HK inno.N Corporation

Unknown

Safety and Immunogenicity of CJ-40010 in Healthy Subjects

Hand, Foot and Mouth Disease

Korea, Republic of
University of Washington
National Cancer Institute (NCI)

Completed

Eribulin Mesylate in Treating Patients With Previously Treated Metastatic Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Carcinoma

United States
Impax Laboratories, LLC

Completed

IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis

Multiple Sclerosis

United States, Canada, Estonia, Latvia, Ukraine
Longeveron Inc.

Completed

Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty (HERA)

Aging Frailty

United States
Augusta University

Unknown

Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II)

Hyperglycemia | Cardiovascular Diseases | Obesity | Insulin Resistance | Hyperlipidemia | Nutritional and Metabolic Diseases | Obesity in Diabetes

United States
Pfizer
Arvinas Estrogen Receptor, Inc.

Recruiting

A Study to Learn How Various Tablets of the Study Medicine Vepdegestrant Are Taken up Into the Blood of Healthy Adults

Healthy

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Terminated

Reducing Lung Cancer-Related Anxiety (RELAX) (RELAX)

Lung Cancer

United States

Search clinical trials for: K-877-ER (Dose B)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations